Retraction: Melanocortin 4 Receptor Stimulation Decreases Pancreatitis Severity in Rats by Activation of the Cholinergic Anti-Inflammatory Pathway (Crit Care Med (2011) 39 (1089-1096) DOI: 10.1097/CCM.0b013e318207ea80);Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway

Critical Care Medicine

Volumn 39, Issue 5, 2011, Pages 1089-1096

  Minutoli, Letteria ^a   Squadrito, Francesco ^a   Nicotina, Piero Antonio ^b   Giuliani, Daniela ^c   Ottani, Alessandra ^c   Polito, Francesca ^a   Bitto, Alessandra ^a   Irrera, Natasha ^a   Guzzo, Giuseppe ^a   Spaccapelo, Luca ^c   Fazzari, Carmine ^b   MacRì, Antonio ^b   Marini, Herbert ^b   Guarini, Salvatore ^c   Altavilla, Domenica ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

efferent vagus activity; melanocortin 4 receptors; nicotinic acetylcholine receptors; pancreatitis

Indexed keywords

AMYLASE; CERULETIDE; CHLORISONDAMINE; HS 024; INTERLEUKIN 6; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MYELOPEROXIDASE; RO 273225; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; CERVICAL VAGOTOMY; CHOLINERGIC STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EFFERENT NERVE; ENZYME ACTIVITY; HISTOPATHOLOGY; INJECTION; MALE; NERVE FIBER; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK REDUCTION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UNIVERSITY HOSPITAL; VAGOTOMY; VAGUS NERVE;

EID: 79955471443     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000005782     Document Type: Erratum

References (40)

1. Granger J, Remick D: Acute pancreatitis: models, markers, and mediators. Shock 2005; 24:45-51
2. Glasbrenner B, Adler G: Pathophysiology of acute pancreatitis. Hepatogastroenterology 1993; 40:517-521 (Pubitemid 24006278)
3. Norman J: The role of cytokines in the patho-genesis of acute pancreatitis. Am J Surg 1998; 175:76-83 (Pubitemid 28047037)
4. Lane JS, Todd KE, Gloor B, et al: Platelet activating factor antagonism reduces the sys-temic inflammatory response in a murine model of acute pancreatitis. J Surg Res 2001; 99:365-370 (Pubitemid 32703461)
5. Salem MZ, Cunha JE, Coelho AM, et al: Ef-fects of octreotide pretreatment in experi-mental acute pancreatitis. Pancreatology 2003; 3:164-168 (Pubitemid 36577079)
6. Mota R, Sánchez-Bueno F, Berenguer-Pina JJ, et al: Therapeutic treatment with poly-(ADP-ribose) polymerase inhibitors attenu-ates the severity of acute pancreatitis and associated liver and lung injury. Br J Phar-macol 2007; 151:998-1005 (Pubitemid 47195526)
7. Seo SW, Jung WS, Piao TG, et al: Selective cyclooxygenase-2 inhibitor ameliorates cho-lecystokinin-octapeptide-induced acute pan-creatitis in rats. WorldJ Gastroenterol 2007; 13:2298-2304
8. Algül H, Schmid RM: [Acute pancreatitis: Etiology, diagnosis and therapy]. Med Monatsschr Pharm 2009; 32:242-247
9. Tatro JB: Receptor biology of the melano-cortins, a family of neuroimmunomodula-tory peptides. Neuroimmunomodulation 1996; 3:259-284 (Pubitemid 27230988)
10. Catania A: Neuroprotective action of melanocortins: A therapeutic opportunity. Trends Neurosci 2008; 31:353-360
11. Catania A, Gatti S, Colombo G, et al: Target-ing melanocortin receptors as a novel strat-egy to control inflammation. Pharmacol Rev 2004; 56:1-29 (Pubitemid 38314578)
12. Getting SJ: Targeting melanocortin recep-tors as potential novel therapeutics. Pharma-col Ther 2006; 111:1-15 (Pubitemid 43765537)
13. Bertolini A, Guarini S, Ferrari W: Adrenal-independent, anti-shock effect of ACTH-(1-24) in rats. Eur J Pharmacol 1986; 122: 387-388 (Pubitemid 16061490)
14. Guarini S, Cainazzo MM, Giuliani D, et al: Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory path-way. Cardiovasc Res 2004; 63:357-365 (Pubitemid 38900850)
15. Noera G, Lamarra M, Guarini S, et al: Sur-vival rate after early treatment for acute type-A aortic dissection with ACTH-(1-24). Lancet 2001; 358:469-470 (Pubitemid 32769856)
16. Guarini S, Schiöth HB, Mioni C, et al: MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion- induced arrhythmias. Naunyn Schmiedebergs Arch Pharmacol 2002; 366: 177-182 (Pubitemid 34762278)
17. Mioni C, Bazzani C, Giuliani D, et al: Activa-tion of an efferent cholinergic pathway pro-duces strong protection against myocardial ischemia/reperfusion injury in rats. Crit Care Med 2005; 33:2621-2628 (Pubitemid 41682117)
18. Bazzani C, Guarini S, Botticelli AR, et al: Protective effect of melanocortin peptides in rat myocardial ischemia. J Pharmacol Exp Ther 2001; 297:1082-1087 (Pubitemid 32472507)
19. Giuliani D, Mioni C, Altavilla D, et al: Both early and delayed treatment with melanocor-tin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral isch-emia. Endocrinology 2006; 147:1126-1135 (Pubitemid 43244343)
20. Ottani A, Giuliani D, Mioni C, et al: Vagus nerve mediates the protective effects of mela-nocortins against cerebral and systemic dam-age after ischemic stroke. J Cereb Blood Flow Metab 2009; 29:512-523
21. Wikberg JE, Muceniece R, Mandrika I, et al: New aspects on the melanocortins and their receptors. Pharmacol Res 2000; 42:393-420
22. Borovikova LV, Ivanova S, Zhang M, et al: Vagus nerve stimulation attenuates the sys-temic inflammatory response to endotoxin. Nature 2000; 405:458-462 (Pubitemid 30367422)
23. Tracey KJ: The inflammatory reflex. Nature 2002; 420:853-859 (Pubitemid 36019638)
24. Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117:289-296 (Pubitemid 46203953)
25. Giuliani D, Ottani A, Altavilla D, et al: Mela-nocortins and the cholinergic anti-inflam-matory pathway. Adv Exp Med Biol 2010; 681:71-87
26. Guarini S, Altavilla D, Cainazzo MM, et al: Efferent vagal fibre stimulation blunts nu-clear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003; 107:1189-1194 (Pubitemid 36297213)
27. Hiramoto T, Chida Y, Sonoda J, et al: The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nic-otinic acetylcholine receptor. Gastroenterol-ogy 2008; 134:2122-2131 (Pubitemid 351783265)
28. van Westerloo DJ, Giebelen IA, Florquin S, et al: The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006; 130: 1822-1830
29. Altavilla D, Famulari C, Passaniti M, et al: Lipid peroxidation inhibition reduces NF-kappaB activation and attenuates cerulein-induced pancreatitis. Free Radic Res 2003; 37:425-435 (Pubitemid 36240407)
30. Giuliani D, Mioni C, Bazzani C, et al: Selec-tive melanocortin MC4 receptor agonists re-verse haemorrhagic shock and prevent mul-tiple organ damage. Br J Pharmacol 2007; 150:595-603 (Pubitemid 46355552)
31. Borovikova LV, Ivanova S, Nardi D, et al: Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 2000; 85:141-147
32. Gross V, Leser HG, Heinisch A, et al: Inflam-matory mediators and cytokines-new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastro-enterology 1993; 40:522-530 (Pubitemid 24006279)
33. Murr MM, Yang J, Fier A, et al: Regulation of Kupffer cell TNF gene expression during ex-perimental acute pancreatitis: the role of p38-MAPK, ERK1/2, SAPK/JNK, and NF-kappaB. J Gastrointest Surg 2003; 7:20-25 (Pubitemid 36875797)
34. Denham W, Norman J: The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg Clin North Am 1999; 79: 767-781 (Pubitemid 29383594)
35. Vonlaufen A, Wilson JS, Apte MV: Molecular mechanisms of pancreatitis: Current opin-ion. J Gastroenterol Hepatol 2008; 23: 1339-1348
36. Banks WA, Kastin AJ: Permeability of the blood-brain barrier to melanocortins. Peptides 1995; 16:1157-1161
37. van Westerloo D, van der Poll T: Acute va-gotomy activates the cholinergic anti-inflammatory pathway. Am J Physiol Heart Circ Physiol 2005; 288:H977-H978; author reply H978-H979
38. van der Zanden EP, Snoek SA, Heinsbroek SE, et al: Vagus nerve activity augments in-testinal macrophage phagocytosis via nico-tinic acetylcholine receptor alpha4beta2. Gastroenterology 2009; 137:1029-1039, 1039e.1-1039e.4
39. Vrinten DH, Kalkman CJ, Adan RA, et al: Neuropathic pain: A possible role for the melanocortin system? Eur J Pharmacol 2001; 429:61-69 (Pubitemid 33043982)
40. Corander MP, Fenech M, Coll AP: Science of self-preservation: How melanocortin action in the brain modulates body weight, blood pressure, and ischemic damage. Circulation 2009; 120:2260-2268